Minimal residual disease negativity does not overcome poor prognosis in high risk multiple myeloma: a single center retrospective study

BACKGROUND: Minimal residual disease (MRD) is a standard measurement for response assessment in multiple myeloma (MM). Despite new treatments, high-risk MM patients continue to have poor prognosis. We evaluated the impact of MRD- in high vs standard- risk patients. METHODS: We retrospectively evalua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Kunacheewa, Chutima, Lee, Hans C., Patel, Krina, Thomas, Sheeba, Behrang, Amini, Srour, Samer, Bashir, Qaiser, Nieto, Yago, Qazilbash, Muzzaffar H., Weber, Donna M., Feng, Lei, Orlowski, Robert Z., Lin, Pei, Manasanch, Elisabet E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190410/
https://ncbi.nlm.nih.gov/pubmed/32037287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.01.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados